Innovating.works Conecta tu I+D

Showing 1 to 20 of 21 results

SYS-LIFE: Systemic approaches to improve cardiometabolic and brain health during lifespan VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-COFUND-01 Systemic approaches to improve cardiometabolic and brain health during lifespan (SYS-LIFE) is an exciting new postdoctoral fellowship progra...
2023-10-17 - 2028-10-31 | Financiado

PROMISE: Preparing for RSV Immunisation and Surveillance in Europe VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-JTI-IMI2-2020-22-single-stage RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progre...
2021-05-21 - 2024-04-30 | Financiado

SLEEP REVOLUTION: Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therap... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-SC1-BHC-2018-2020 Obstructive sleep apnea (OSA) is associated with various negative health consequences including increased risk of heart disease, hypertensio...
2021-02-01 - 2025-02-28 | Financiado

DECIDER: Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-SC1-BHC-2018-2020 The goals of this inter-disciplinary project are to 1) gain understanding of the mechanisms causing chemoresistance in high-grade serous ova...
2021-01-21 - 2026-07-31 | Financiado

FURTHER: Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-SC1-BHC-2018-2020 "Bone metastases are a common manifestation of advanced cancer, with pain as a devastating consequence. Due to rising cancer incidence rates...
2018-12-05 - 2025-12-31 | Financiado

BEAt-DKD: Biomarker Enterprise to Attack DKD Sofia ref. 115974 VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-JTI-IMI2-2015-05-two-stage Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached e...
2016-12-20 - 2023-08-31 | Financiado

RESCEU: REspiratory Syncytial virus Consortium in EUrope Sofia ref. 116019 VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk gr...
2016-12-14 - 2022-09-30 | Financiado

HERCULES: Comprehensive characterization and effective combinatorial targeting of high grade serous ovarian ca... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-PHC-2014-2015 The goal of this multidisciplinary project is to comprehensively characterise high-grade serous ovarian cancer (HGS-OvCa) at single-cell lev...
2015-12-02 - 2021-06-30 | Financiado

SMARTool: Simulation Modeling of coronary ARTery disease a tool for clinical decision support VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un H2020: H2020-PHC-2014-2015 SMARTool aims at developing a platform based on cloud technology, for the management of patients with coronary artery disease (CAD) by stand...
2015-11-11 - 2019-06-30 | Financiado

TORNADO: Molecular Targets Open for Regulation by the gut flora New Avenues for improved Diet to Optimize E... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: Europe is facing major diet related health problems. Attitudes to eating habits have to be changed and the benefits of alternative treatment...
Financiado

INMIND: Imaging of Neuroinflammation in Neurodegenerative Diseases VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: The goal of this proposal (INMiND) is to carry out collaborative research on molecular mechanisms that link neuroinflammation with neurodege...
Financiado

EUROHYP-1: European multicentre randomised phase III clinical trial of hypothermia plus best medical treatmen... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial w...
Financiado

DIAPREPP: DIAbetes type 1 PRediction Early Pathogenesis and Prevention VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: The earliest currently identifiable process in the pathogenesis of type 1 diabetes (T1D) is the development of autoimmunity to islet beta ce...
Financiado

ClinicIMPPACT: Clinical Intervention Modelling Planning and Proof for Ablation Cancer Treatment VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: The ClinicIMPPACT proposal builds upon the successful completion of the IMPPACT project (Grant No. 223877, completed in February 2012) that...
Financiado

TBIcare: Evidence based Diagnostic and Treatment Planning Solution for Traumatic Brain Injuries VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: Traumatic brain injury (TBI) occurs when a sudden trauma causes damage to the brain – it is a major health problem and the most common cause...
Financiado

DOPPLER-CIP: Determining Optimal non invasive Parameters for the Prediction of Left vEntricular morphologic and f... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: Coronary artery disease (CAD) remains the primary cause of cardiovascular morbidity and mortality in Europe. In current clinical practice, p...
Financiado

INTREALL: International study for treatment of childhood relapsed ALL 2010 with standard therapy systematic i... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood...
Financiado

ACUSEP: Integrated whole blood acoustophoresis and homogeneous nucleic acid detection cartridge for rapid se... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: The objective of the ACUSEP research project is to develop an integrated, dry-reagent based disposable ready-to-use cartridge enabling rapid...
Financiado

DISCHARGE: Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary... VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference s...
Financiado

CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA participó en un FP7: Traumatic Brain Injury (TBI) is a major cause of death and disability, leading to great personal suffering to victim and relatives, as well...
Financiado

TUCH